Zhende Medical Co., Ltd. (603301) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Zhende Medical Co., Ltd.

Why is Zhende Medical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -2.71% and Operating profit at -26.44% over the last 5 years

The company has declared negative results in Mar'2025 after 2 consecutive positive quarters

OPERATING CASH FLOW(Y) Lowest at CNY 407.07 MM
DEBT-EQUITY RATIO (HY) Highest at -1.87 %
INTEREST(Q) At CNY 5.41 MM has Grown at 12.5%

With ROE of 6.50%, it has a attractive valuation with a 1.64 Price to Book Value

Over the past year, while the stock has generated a return of 214.17%, its profits have risen by 147% ; the PEG ratio of the company is 0.2
At the current price, the company has a high dividend yield of 1.9

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Zhende Medical Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Zhende Medical Co., Ltd.

221.16%

5.92

43.21%

China Shanghai Composite

15.19%

1.01

14.58%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-2.71%

EBIT Growth (5y)

-26.44%

EBIT to Interest (avg)

50.41

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.02

Sales to Capital Employed (avg)

0.69

Tax Ratio

17.09%

Dividend Payout Ratio

44.94%

Pledged Shares

Institutional Holding

ROCE (avg)

36.27%

ROE (avg)

21.96%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.64

EV to EBIT

29.69

EV to EBITDA

16.42

EV to Capital Employed

1.64

EV to Sales

2.17

PEG Ratio

0.17

Dividend Yield

1.88%

ROCE (Latest)

5.51%

ROE (Latest)

6.50%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -7.08% (YoY

NET PROFIT(9M)

Higher at CNY 281.8 MM

-19What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 407.07 MM

DEBT-EQUITY RATIO (HY)

Highest at -1.87 %

INTEREST(Q)

At CNY 5.41 MM has Grown at 12.5%

INTEREST COVERAGE RATIO(Q)

Lowest at 1,036.27

OPERATING PROFIT(Q)

Lowest at CNY 56.03 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 5.74 %

PRE-TAX PROFIT(Q)

Lowest at CNY 58.39 MM

NET PROFIT(Q)

Lowest at CNY 48.24 MM

EPS(Q)

Lowest at CNY 0.19

Here's what is working for Zhende Medical Co., Ltd.

Raw Material Cost

Fallen by -7.08% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Zhende Medical Co., Ltd.

Operating Cash Flow

Lowest at CNY 407.07 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Interest

At CNY 5.41 MM has Grown at 12.5%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 1,036.27

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Pre-Tax Profit

At CNY 58.39 MM has Fallen at -52.19%

over average net sales of the previous four periods of CNY 122.13 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 48.24 MM has Fallen at -51.22%

over average net sales of the previous four periods of CNY 98.89 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Debt-Equity Ratio

Highest at -1.87 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Operating Profit

Lowest at CNY 56.03 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 5.74 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at CNY 58.39 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit

Lowest at CNY 48.24 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS

Lowest at CNY 0.19

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)